$512 Million is the total value of VR Adviser, LLC's 25 reported holdings in Q1 2023. The portfolio turnover from Q4 2022 to Q1 2023 was 77.8% .
| Value | Shares | ↓ Weighting | ||||||
|---|---|---|---|---|---|---|---|---|
| TERN | Sell | TERNS PHARMACEUTICALS INC | $42,855,140 | +13.5% | 3,619,522 | -2.4% | 8.37% | +31.6% |
| ACRS | Sell | ACLARIS THERAPEUTICS INC | $8,419,700 | -88.3% | 1,040,754 | -77.2% | 1.64% | -86.4% |
| LIFE | Exit | ATYR PHARMA INC | $0 | – | -1,171,436 | -100.0% | -0.43% | – |
| INZY | Exit | INOZYME PHARMA INC | $0 | – | -2,709,987 | -100.0% | -0.48% | – |
| Exit | MARINUS PHARMACEUTICALS INC | $0 | – | -1,770,705 | -100.0% | -1.19% | – | |
| Exit | LIANBIOsponsored ads | $0 | – | -4,793,047 | -100.0% | -1.32% | – | |
| PRVB | Exit | PROVENTION BIO INC | $0 | – | -1,118,653 | -100.0% | -1.99% | – |
| NVAX | Exit | NOVAVAX INC | $0 | – | -1,879,894 | -100.0% | -3.26% | – |
| AXSM | Exit | AXSOME THERAPEUTICS INC | $0 | – | -670,718 | -100.0% | -8.72% | – |
Original filings
The following EDGAR filing(s) were analyzed to create this report:
- View 13F-HR filed 2023-05-15
Top long-term holdings
| Name | Quarters owned | Latest quarter owned | Max weighting |
|---|---|---|---|
| ACLARIS THERAPEUTICS INC | 12 | Q3 2023 | 12.7% |
| VIRIDIAN THERAPEUTICS INC | 12 | Q3 2023 | 13.4% |
| COGENT BIOSCIENCES INC | 12 | Q3 2023 | 10.3% |
| RELMADA THERAPEUTICS INC | 11 | Q3 2022 | 9.9% |
| GH RESEARCH PLC | 10 | Q3 2023 | 6.7% |
| ALTIMMUNE INC | 9 | Q3 2022 | 11.6% |
| MARINUS PHARMACEUTICALS INC | 9 | Q4 2022 | 5.7% |
| CELLDEX THERAPEUTICS INC | 9 | Q3 2022 | 7.6% |
| AFFIMED N V | 8 | Q3 2023 | 1.1% |
| INSTIL BIO INC | 7 | Q3 2022 | 18.7% |
View VR Adviser, LLC's complete holdings history.
Latest filings
| Type | Filed |
|---|---|
| 13F-HR | 2024-05-15 |
| 13F-HR | 2024-02-14 |
| 13F-HR | 2023-11-14 |
| 13F-HR | 2023-08-11 |
| 13F-HR/A | 2023-05-15 |
| 13F-HR/A | 2023-05-15 |
| 13F-HR/A | 2023-05-15 |
| 13F-HR | 2023-05-15 |
| 13F-HR | 2023-02-14 |
| 13F-HR | 2022-11-14 |
View VR Adviser, LLC's complete filings history.
All filings
- Holdings (13F-HR)
- Significant ownership (13-D/G)
- Insider transactions (4, 5, 6)
- Events (8-K)
- Shareholder votes (proxy)
View complete filings history.